NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.92+0.02 (+1.05%)
Close on Nov 19, 2026Market cap $152.93MP/E –Yield –
NervGen Pharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for NervGen Pharma
NervGen Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?